Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Super DNA Sequencing Facility Planned

By Biotechdaily staff writers
Posted on 19 Aug 2002
J. More...
Craig Venter has announced plans to create a next-generation high-throughput DNA sequencing facility in Rockville, MD (USA). He will be aided by The Institute for Genomic Research (TIGR), the Institute for Biological Energy Alternatives (IBEA), and The Center for the Advancement of Genomics (TCAG), all of which he founded. All are not-for-profit organizations supported by the J. Craig Venter Science Foundation, which will provide administrative support and coordinate policy and research activities. The new facility will also be not-for-profit and will make information freely available to researchers, not selling it as Celera Genomics did.

As the head of Celera Genomics, Dr. Venter was responsible, along with a US government group, for completing the first sequencing of the human genome. The results have enabled researchers to make many new medical findings and develop new drugs. However, as Dr. Venter points out, even though the cost of sequencing a species has rapidly declined from billions to millions of dollars, there is still a need to substantially reduce these costs even further so more people can benefit from the great promise that genomics holds.

TIGR, TCAG, and IBEA are building a facility to rapidly sequence and analyze genomes in a more cost-effective manner. The new facility will utilize the latest developments in automated DNA sequencing, supercomputing, networking, and high-performance storage technologies. The center will also house a research and development laboratory that will explore advanced technologies from a variety of vendors. Research projects include continuation of ongoing biologic energy research that is seeking new organisms and analyzing known organisms that metabolize carbon or create hydrogen. Another project planned will be to use sequencing to better understand ethno-geographic differences among populations.

"As we continue to explore the implications of individual genetic sequences, this information needs to rapidly become an integral part of medical care and preventive medicine,” said Dr. Venter. "One of our goals in building this facility is to make genomic sequencing of the six billion people on this planet technologically feasible so that everyone can benefit and be empowered by this information.”




Related Links:
TIGR

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
POC Immunoassay Analyzer
Procise DX
Automated Clinical Chemistry Analyzer
Envoy 500+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.